How base editing corrected a faulty gene inside a patient's liver
In a clinical trial, scientists used base editing directly inside a patient's liver to correct over half of the mutated genes causing Alpha-1 antitrypsin deficiency.
Reading level
The full story with proper science words explained.
A single letter out of place
Imagine reading an instruction manual where a single wrong letter ruins the entire machine. In Alpha-1 antitrypsin deficiency (AATD), one faulty DNA letter in the SERPINA1 gene causes liver cells to produce abnormal, misfolded proteins. These clump together, damaging the liver and leaving the lungs unprotected from tissue-destroying enzymes.
Standard treatments cannot cure the condition. To fix the root cause, researchers turned to base editing. Instead of cutting through both strands of DNA, base editing chemically swaps one genetic letter directly inside the living body. A 66-year-old male patient with the severe PI*ZZ genotype received this in vivo treatment to repair his liver cells on the spot.
Inspecting the factory floor
Ten weeks after treatment, doctors took a liver biopsy to see whether the molecular tools had worked. Sanger sequencing showed that 54% of the target alleles were corrected, while Illumina sequencing measured 57% correction. This shift allowed liver cells to release functional AAT protein rather than trapping dangerous clumps inside.
Equally important was accuracy. Sequencing showed no detected off-target editing across other parts of the genome, and no unwanted bystander editing at neighbouring letters. While the patient showed an early spike in transaminases—enzymes that leak when liver cells are stressed—the levels soon returned to baseline, and tissue samples showed no persistent inflammation. Blood tests confirmed steady, biologically active AAT capable of blocking destructive enzymes.
What we still do not know
These results come from a single clinical trial participant, meaning they do not establish wide clinical efficacy or prove that pre-existing liver fibrosis will resolve over time. Scientists still do not know why the temporary enzyme spike occurred, or whether the repair will remain durable across years. Further trials across broader groups will test whether rewriting DNA letters inside human organs can reliably treat genetic illness.
Science words
- Base editing
- A method that directly converts one DNA letter into another without cutting both strands of the DNA molecule.
- PI*ZZ genotype
- A genetic profile with two copies of the severe mutation in the SERPINA1 gene.
- Off-target editing
- Unintended genetic alterations occurring at different sites across the genome.
- Bystander editing
- Unwanted alterations to neighbouring DNA letters right next to the intended target site.
- Transaminases
- Liver enzymes that escape into the bloodstream when liver cells experience stress or injury.
Check it yourself
This story is based on a real research paper in Journal of Hepatology by Krooss, Yang, Yuan et al. We write with AI help and check it against the paper, but the original is the final word.